Patten SB, Beck CA, Kassam A et al. Long-term medical conditions and major depression: strength of association for specific conditions in the general population. Can J Psychiatry 2005;50:195–202.
Graff LA, Walker JR, Bernstein CN. Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis 2009;15:1105–1118.
Hauser W, Janke KH, Klump B et al. Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population. Inflamm Bowel Dis 2011;17:621–632.
Fuller-Thomson E, Sulman J. Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys. Inflamm Bowel Dis 2006;12:697–707.
Yanartas O, Kani HT, Bicakci E et al. The effects of psychiatric treatment on depression, anxiety, quality of life, and sexual dysfunction in patients with inflammatory bowel disease. Neuropsychiatr Dis Treat 2016;12:673–683.
Mikocka-Walus A, Pittet V, Rossel JB et al. Symptoms of depression and anxiety are independently associated with clinical recurrence of inflammatory bowel disease. Clin Gastroenterol Hepatol 2016;14:829–835 e1.
Bel LG, Vollebregt AM, Van der Meulen-de Jong AE et al. Sexual dysfunctions in men and women with inflammatory bowel disease: the influence of IBD-related clinical factors and depression on sexual function. J Sex Med 2015;12:1557–1567.
Panara AJ, Yarur AJ, Rieders B et al. The incidence and risk factors for developing depression after being diagnosed with inflammatory bowel disease: a cohort study. Aliment Pharmacol Ther 2014;39:802–810.
Mittermaier C, Dejaco C, Waldhoer T et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med 2004;66:79–84.
Kim MC, Jung YS, Song YS et al. Factors associated with anxiety and depression in Korean patients with inactive inflammatory bowel disease. Gut Liver 2016;10:399–405.
Gradus JL, Qin P, Lincoln AK et al. Inflammatory bowel disease and completed suicide in Danish adults. Inflamm Bowel Dis 2010;16:2158–2161.
Englund H, Liden KK, Lind T et al. Radiation exposure in patients with inflammatory bowel disease and irritable bowel syndrome in the years 2001-2011. Scand J Gastroenterol 2016, 1–6.
Long MD, Kappelman MD, Martin CF et al. Risk factors for depression in the elderly inflammatory bowel disease population. J Crohns Colitis 2014;8:113–119.
Addolorato G, Capristo E, Stefanini GF et al. Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status. Scand J Gastroenterol 1997;32:1013–1021.
Szigethy EM, Youk AO, Benhayon D et al. Depression subtypes in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2014;58:574–581.
Zhang CK, Hewett J, Hemming J et al. The influence of depression on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis 2013;19:1732–1739.
Nahon S, Lahmek P, Durance C et al. Risk factors of anxiety and depression in inflammatory bowel disease. Inflamm Bowel Dis 2012;18:2086–2091.
Filipovic BR, Filipovic BF, Kerkez M et al. Depression and anxiety levels in therapy-naive patients with inflammatory bowel disease and cancer of the colon. World J Gastroenterol 2007;13:438–443.
Kurina LM, Goldacre MJ, Yeates D et al. Depression and anxiety in people with inflammatory bowel disease. J Epidemiol Community Health 2001;55:716–720.
Harvey RF, Bradshw JM. A simple index of Crohn’s-disease activity. Lancet 1980;1:514.
Walmsley RS, Ayers RC, Pounder RE et al. A simple clinical colitis activity index. Gut 1998;43:29–32.
Razykov I, Ziegelstein RC, Whooley MA et al. The PHQ-9 versus the PHQ-8—is item 9 useful for assessing suicide risk in coronary artery disease patients? Data from the Heart and Soul Study. J Psychosom Res 2012;73:163–168.
Corson K, Gerrity MS, Dobscha SK. Screening for depression and suicidality in a VA primary care setting: 2 items are better than 1 item. Am J Manag Care 2004;10:839–845.
Kroenke K, Spitzer RL, Williams JB et al. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. Gen Hosp Psychiatry 2010;32:345–359.
Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann 2002;32:509–515.
Cameron IM, Crawford JR, Lawton K et al. Psychometric comparison of PHQ-9 and HADS for measuring depression severity in primary care. Br J Gen Pract 2008;58:32–36.
Stafford L, Berk M, Jackson HJ. Validity of the Hospital Anxiety and Depression Scale and Patient Health Questionnaire-9 to screen for depression in patients with coronary artery disease. Gen Hosp Psychiatry 2007;29:417–424.
Kroenke K, Strine TW, Spitzer RL et al. The PHQ-8 as a measure of current depression in the general population. J Affect Disord 2009;114:163–173.
Matcham F, Ali S, Irving K et al. Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective study. BMC Musculoskelet Disord 2016;17:155.
Matcham F, Norton S, Scott DL et al. Symptoms of depression and anxiety predict treatment response and long-term physical health outcomes in rheumatoid arthritis: secondary analysis of a randomized controlled trial. Rheumatology (Oxford) 2016;55:268–278.
Aberra TM, Joshi AA, Lerman JB et al. Self-reported depression in psoriasis is associated with subclinical vascular diseases. Atherosclerosis 2016;251:219–225.
Ghia JE, Blennerhassett P, Deng Y et al. Reactivation of inflammatory bowel disease in a mouse model of depression. Gastroenterology 2009;136:2280–2288 e1-4.
Brandstetter S, Riedelbeck G, Steinmann M et al. Depression moderates the associations between beliefs about medicines and medication adherence in patients with rheumatoid arthritis: cross-sectional study. J Health Psychol 2016 [e-pub ahead of print].
Keerthy D, Youk A, Srinath AI et al. Effect of psychotherapy on healthcare utilization in children with inflammatory bowel disease and depression. J Pediatr Gastroenterol Nutr 2016;63:658–664.
Long MD, Barnes EL, Herfarth HH et al. Narcotic use for inflammatory bowel disease and risk factors during hospitalization. Inflamm Bowel Dis 2012;18:869–876.
Cross RK, Wilson KT, Binion DG. Narcotic use in patients with Crohn’s disease. Am J Gastroenterol 2005;100:2225–2229.
Lichtenstein GR, Feagan BG, Cohen RD et al. Serious infections and mortality in association with therapies for Crohn’s disease: TREAT registry. Clin Gastroenterol Hepatol 2006;4:621–630.
Ananthakrishnan AN, Kwon J, Raffals L et al. Variation in treatment of patients with inflammatory bowel diseases at major referral centers in the United States. Clin Gastroenterol Hepatol 2015;13:1197–1200.